AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionTrifecta Capital Advisors, LLC
Latest Disclosed Ownership40,702 shares
Latest Disclosed Value $ 8,852,285
Trifecta Capital Advisors, LLC reports 0.39% increase in ownership of ABBV / AbbVie Inc.

On May 1, 2026 - Trifecta Capital Advisors, LLC filed a 13F-HR form disclosing ownership of 40,702 shares of AbbVie Inc. (US:ABBV) valued at $8,852,278 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 40,542 shares of AbbVie Inc.. This represents a change in shares of 0.39% during the quarter. The current value of the position is $9,248,715 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F ABBVIE COM 00287Y109 40,702 160 0.39 8,852 -4.44 1.3703
2026-01-30 2025-12-31 13F ABBVIE COM 00287Y109 40,542 614 1.54 9,263 0.21 1.3708
2025-11-03 2025-09-30 13F ABBVIE COM 00287Y109 39,928 900 2.31 9,245 27.61 1.4056
2025-07-23 2025-06-30 13F ABBVIE COM 00287Y109 39,028 1,664 4.45 7,244 -7.46 1.2057
2025-04-21 2025-03-31 13F ABBVIE COM 00287Y109 37,364 907 2.49 7,828 20.84 1.6405
2025-02-04 2024-12-31 13F ABBVIE COM 00287Y109 36,457 6,474 21.59 6,478 9.41 1.2794
2024-10-16 2024-09-30 13F ABBVIE COM 00287Y109 29,983 148 0.50 5,921 15.71 1.2392
2024-08-07 2024-06-30 13F ABBVIE COM 00287Y109 29,835 1,070 3.72 5,117 -2.31 1.1329
2024-04-16 2024-03-31 13F ABBVIE COM 00287Y109 28,765 26,480 1,158.86 5,238 1,379.66 1.2750
2024-01-25 2023-12-31 13F ABBVIE COM 00287Y109 2,285 -230 -9.15 354 -5.35 0.0979
2023-11-01 2023-09-30 13F ABBVIE COM 00287Y109 2,515 -29 -1.14 375 9.36 0.1205
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 2,544 0 0.00 343 -15.56 0.1103
2023-05-09 2023-03-31 13F ABBVIE COM 00287Y109 2,544 29 1.15 405 -0.25 0.1428
2023-01-18 2022-12-31 13F ABBVIE COM 00287Y109 2,515 2,515 406 0.1620
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.